During the third quarter, GDS Wealth Management reduced its position in UnitedHealth Group by 10.7%, selling 5,297 shares and ending the period with 44,252 shares. Cullen/Frost Bankers also trimmed its holding by 27.1%, offloading 29,527 shares to finish with 79,459 shares. These moves follow similar rotations by other institutions: LFA Lugano Financial Advisors added a new position worth $25,000, Sagard Holdings invested $29,000, Grey Fox Wealth Advisors allocated $33,000, and Riggs Asset Management boosted its stake by 69.4% to 105 shares, collectively underscoring a wave of portfolio rebalancing among major investors.

In its latest quarterly report, UnitedHealth Group delivered adjusted earnings per share of $2.92, surpassing consensus estimates by $0.05. Revenue grew 12.2% year-over-year to $113.16 billion, nearly matching analyst forecasts. Net margin stood at 4.04% and return on equity was 19.23%. While year-ago adjusted EPS included a one-time benefit of $7.15, the current results reflect ongoing growth in both UnitedHealthcare membership and Optum services volume, positioning the company for continued top-line expansion.

Research firms remain broadly constructive, with Jefferies raising its price objective by $92 to endorse a “buy” rating, UBS boosting its target by $52, Goldman Sachs initiating coverage with a buy recommendation, and Mizuho reiterating its buy view ahead of the upcoming Medicare Advantage 2027 notice. Conversely, Piper Sandler trimmed its target by $6 while maintaining an overweight stance. Of 29 analysts covering the stock, 18 rate it buy or strong buy, nine hold, and two recommend sell, resulting in a consensus moderate-buy rating and an average target implying mid-single-digit upside.

UnitedHealth Group declared a quarterly dividend of $2.21 per share, translating to an annualized payout of $8.84 and a yield near 2.5%. The payout ratio stands at 46.1%, reflecting a balanced approach to shareholder return versus reinvestment. At quarter-end, the company’s debt-to-equity ratio was 0.71, with current and quick ratios both at 0.82, indicating sufficient short-term liquidity. With a beta below 0.5, the business offers defensive characteristics amid broader market volatility.